<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32579787</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-1004</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Human mutation</Title><ISOAbbreviation>Hum Mutat</ISOAbbreviation></Journal><ArticleTitle>Revisiting the complex architecture of ALS in Turkey: Expanding genotypes, shared phenotypes, molecular networks, and a public variant database.</ArticleTitle><Pagination><StartPage>e7</StartPage><EndPage>e45</EndPage><MedlinePgn>e7-e45</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/humu.24055</ELocationID><Abstract><AbstractText>The last decade has proven that amyotrophic lateral sclerosis (ALS) is clinically and genetically heterogeneous, and that the genetic component in sporadic cases might be stronger than expected. This study investigates 1,200 patients to revisit ALS in the ethnically heterogeneous yet inbred Turkish population. Familial ALS (fALS) accounts for 20% of our cases. The rates of consanguinity are 30% in fALS and 23% in sporadic ALS (sALS). Major ALS genes explained the disease cause in only 35% of fALS, as compared with ~70% in Europe and North America. Whole exome sequencing resulted in a discovery rate of 42% (53/127). Whole genome analyses in 623 sALS cases and 142 population controls, sequenced within Project MinE, revealed well-established fALS gene variants, solidifying the concept of incomplete penetrance in ALS. Genome-wide association studies (GWAS) with whole genome sequencing data did not indicate a new risk locus. Coupling GWAS with a coexpression network of disease-associated candidates, points to a significant enrichment for cell cycle- and division-related genes. Within this network, literature text-mining highlights DECR1, ATL1, HDAC2, GEMIN4, and HNRNPA3 as important genes. Finally, information on ALS-related gene variants in the Turkish cohort sequenced within Project MinE was compiled in the GeNDAL variant browser (www.gendal.org).</AbstractText><CopyrightInformation>&#xa9; 2020 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tunca</LastName><ForeName>Ceren</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0657-6348</Identifier><AffiliationInfo><Affiliation>Suna and &#x130;nan K&#x131;ra&#xe7; Foundation, Neurodegeneration Research Laboratory (NDAL), Research Center for Translational Medicine (KUTTAM), Ko&#xe7; University School of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Suna and &#x130;nan K&#x131;ra&#xe7; Foundation, Neurodegeneration Research Laboratory (NDAL), Department of Molecular Biology and Genetics, Bo&#x11f;azi&#xe7;i University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x15e;eker</LastName><ForeName>Tuncay</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4567-627X</Identifier><AffiliationInfo><Affiliation>Genomize Inc., Bo&#x11f;azi&#xe7;i University Technology Development Region, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ak&#xe7;imen</LastName><ForeName>Fulya</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0931-5247</Identifier><AffiliationInfo><Affiliation>Suna and &#x130;nan K&#x131;ra&#xe7; Foundation, Neurodegeneration Research Laboratory (NDAL), Department of Molecular Biology and Genetics, Bo&#x11f;azi&#xe7;i University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Co&#x15f;kun</LastName><ForeName>Cemre</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Suna and &#x130;nan K&#x131;ra&#xe7; Foundation, Neurodegeneration Research Laboratory (NDAL), Department of Molecular Biology and Genetics, Bo&#x11f;azi&#xe7;i University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bayraktar</LastName><ForeName>Elif</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Suna and &#x130;nan K&#x131;ra&#xe7; Foundation, Neurodegeneration Research Laboratory (NDAL), Research Center for Translational Medicine (KUTTAM), Ko&#xe7; University School of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palvadeau</LastName><ForeName>Robin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Suna and &#x130;nan K&#x131;ra&#xe7; Foundation, Neurodegeneration Research Laboratory (NDAL), Research Center for Translational Medicine (KUTTAM), Ko&#xe7; University School of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zor</LastName><ForeName>Seyit</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Genomize Inc., Bo&#x11f;azi&#xe7;i University Technology Development Region, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko&#xe7;o&#x11f;lu</LastName><ForeName>Cemile</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2055-6607</Identifier><AffiliationInfo><Affiliation>Suna and &#x130;nan K&#x131;ra&#xe7; Foundation, Neurodegeneration Research Laboratory (NDAL), Department of Molecular Biology and Genetics, Bo&#x11f;azi&#xe7;i University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kartal</LastName><ForeName>Ece</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7720-455X</Identifier><AffiliationInfo><Affiliation>Suna and &#x130;nan K&#x131;ra&#xe7; Foundation, Neurodegeneration Research Laboratory (NDAL), Department of Molecular Biology and Genetics, Bo&#x11f;azi&#xe7;i University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x15e;en</LastName><ForeName>Nesli Ece</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>Suna and &#x130;nan K&#x131;ra&#xe7; Foundation, Neurodegeneration Research Laboratory (NDAL), Department of Molecular Biology and Genetics, Bo&#x11f;azi&#xe7;i University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamzeiy</LastName><ForeName>Hamid</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-7990-2530</Identifier><AffiliationInfo><Affiliation>Suna and &#x130;nan K&#x131;ra&#xe7; Foundation, Neurodegeneration Research Laboratory (NDAL), Department of Molecular Biology and Genetics, Bo&#x11f;azi&#xe7;i University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;zo&#x11f;uz Erimi&#x15f;</LastName><ForeName>Asl&#x131;han</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Suna and &#x130;nan K&#x131;ra&#xe7; Foundation, Neurodegeneration Research Laboratory (NDAL), Department of Molecular Biology and Genetics, Bo&#x11f;azi&#xe7;i University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norman</LastName><ForeName>Utku</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Computer Engineering, Bilkent University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karakahya</LastName><ForeName>O&#x11f;uzhan</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Computer Engineering, Bilkent University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olgun</LastName><ForeName>G&#xfc;lden</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Computer Engineering, Bilkent University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akg&#xfc;n</LastName><ForeName>Tahsin</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Reanimation, American Hospital, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durmu&#x15f;</LastName><ForeName>Hacer</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Istanbul Medical School, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x15e;ahin</LastName><ForeName>Erdi</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Istanbul Medical School, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc7;akar</LastName><ForeName>Arman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Istanbul Medical School, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ba&#x15f;ar G&#xfc;rsoy</LastName><ForeName>Esra</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, Bezmialem Vak&#x131;f University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babacan Y&#x131;ld&#x131;z</LastName><ForeName>G&#xfc;lsen</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, Bezmialem Vak&#x131;f University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x130;&#x15f;ak</LastName><ForeName>Bar&#x131;&#x15f;</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Marmara University School of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ulu&#xe7;</LastName><ForeName>Kay&#x131;han</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Marmara University School of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hana&#x11f;as&#x131;</LastName><ForeName>Ha&#x15f;met</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Istanbul Medical School, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilgi&#xe7;</LastName><ForeName>Ba&#x15f;ar</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Istanbul Medical School, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turgut</LastName><ForeName>Nilda</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nam&#x131;k Kemal University School of Medicine, Tekirda&#x11f;, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aysal</LastName><ForeName>Fikret</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medipol University School of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erta&#x15f;</LastName><ForeName>Mustafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Istanbul Medical School, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boz</LastName><ForeName>Cavit</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Karadeniz Technical University School of Medicine, Trabzon, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotan</LastName><ForeName>Dilcan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, Sakarya University, Sakarya, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x130;driso&#x11f;lu</LastName><ForeName>Halil</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Istanbul Medical School, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soysal</LastName><ForeName>Aysun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Bak&#x131;rk&#xf6;y Research and Training Hospital for Neurologic and Psychiatric Diseases, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uzun Adatepe</LastName><ForeName>Nurten</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Cerrahpa&#x15f;a Medical School, Istanbul University-Cerrahpa&#x15f;a, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akal&#x131;n</LastName><ForeName>Mehmet Ali</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Cerrahpa&#x15f;a Medical School, Istanbul University-Cerrahpa&#x15f;a, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko&#xe7;</LastName><ForeName>Filiz</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, &#xc7;ukurova University Medical School, Adana, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Ersin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hacettepe University Medical School, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oflazer</LastName><ForeName>Piraye</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Istanbul Medical School, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deymeer</LastName><ForeName>Feza</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Istanbul Medical School, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ta&#x15f;tan</LastName><ForeName>&#xd6;znur</ForeName><Initials>&#xd6;</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Engineering, Sabanc&#x131; University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc7;i&#xe7;ek</LastName><ForeName>A Erc&#xfc;ment</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Computer Engineering, Bilkent University, Ankara, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computational Biology, Carnegie Mellon University, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kavak</LastName><ForeName>Er&#x15f;en</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Genomize Inc., Bo&#x11f;azi&#xe7;i University Technology Development Region, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parman</LastName><ForeName>Ye&#x15f;im</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Istanbul Medical School, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ba&#x15f;ak</LastName><ForeName>A Nazl&#x131;</ForeName><Initials>AN</Initials><Identifier Source="ORCID">0000-0001-6977-2517</Identifier><AffiliationInfo><Affiliation>Suna and &#x130;nan K&#x131;ra&#xe7; Foundation, Neurodegeneration Research Laboratory (NDAL), Research Center for Translational Medicine (KUTTAM), Ko&#xe7; University School of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Suna and &#x130;nan K&#x131;ra&#xe7; Foundation, Neurodegeneration Research Laboratory (NDAL), Department of Molecular Biology and Genetics, Bo&#x11f;azi&#xe7;i University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Mutat</MedlineTA><NlmUniqueID>9215429</NlmUniqueID><ISSNLinking>1059-7794</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D030541" MajorTopicYN="N">Databases, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014421" MajorTopicYN="N" Type="Geographic">Turkey</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073336" MajorTopicYN="N">Whole Genome Sequencing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">ALS variant database</Keyword><Keyword MajorTopicYN="N">Turkish peninsula</Keyword><Keyword MajorTopicYN="N">clinical exome sequencing</Keyword><Keyword MajorTopicYN="N">coexpression network analysis</Keyword><Keyword MajorTopicYN="N">genetics</Keyword><Keyword MajorTopicYN="N">genome-wide association study</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword><Keyword MajorTopicYN="N">next generation sequencing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32579787</ArticleId><ArticleId IdType="doi">10.1002/humu.24055</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Ak&#xe7;imen, F., Vural, A., Durmu&#x15f;, H., &#xc7;akar, A., Houlden, H., Parman, Y. G., &amp; Nazl&#x131; Ba&#x15f;ak, A. (2019). A novel homozygous FBXO38 variant causes an early-onset distal hereditary motor neuronopathy type IID. Journal of Human Genetics, 64, 1141-1144. https://doi.org/10.1038/s10038-019-0652-y</Citation></Reference><Reference><Citation>Al-Saif, A., Al-Mohanna, F., &amp; Bohlega, S. (2011). A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Annals of Neurology, 70(6), 913-919. https://doi.org/10.1002/ana.22534</Citation></Reference><Reference><Citation>Andersen, P. (2006). Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Current Neurology and Neuroscience Reports, 6(1), 37-46.</Citation></Reference><Reference><Citation>Andersen, P., Nilsson, P., Ala-Hurula, V., Ker&#xe4;nen, M. L., Tarvainen, I., Haltia, T., &#x2026; Marklund, S. L. (1995). Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nature Genetics, 10, 61-66. https://doi.org/10.1038/ng0595-61</Citation></Reference><Reference><Citation>Annesi, G., Savettieri, G., Pugliese, P., D'Amelio, M., Tarantino, P., Ragonese, P., &#x2026; Quattrone, A. (2005). DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex. Annals of Neurology, 58, 803-807. https://doi.org/10.1002/ana.20666</Citation></Reference><Reference><Citation>Auton, A., Abecasis, G. R., Altshuler, D. M., Durbin, R. M., Bentley, D. R., Chakravarti, A., &#x2026; Schloss, J. A. (2015). A global reference for human genetic variation. Nature, 526, 68-74. https://doi.org/10.1038/nature15393</Citation></Reference><Reference><Citation>Battistini, S., Benigni, M., Ricci, C., &amp; Rossi, A. (2013). SOD1 mutations in amyotrophic lateral sclerosis. European Neurological Journal, 252(7), 782-788. https://doi.org/10.1007/s00415-005-0742-y</Citation></Reference><Reference><Citation>Brenner, D., Yilmaz, R., M&#xfc;ller, K., Grehl, T., Petri, S., Meyer, T., &#x2026; Kassubek, J. (2018). Hot-spot KIF5A mutations cause familial ALS. Brain, 141(3), 688-697. https://doi.org/10.1093/brain/awx370</Citation></Reference><Reference><Citation>Brown, R. H., &amp; Al-Chalabi, A. (2017). Amyotrophic lateral sclerosis. New England Journal of Medicine, 377(2), 162-172. https://doi.org/10.1056/NEJMra1603471</Citation></Reference><Reference><Citation>Chen, Y.-Z., Bennett, C. L., Huynh, H. M., Blair, I. P., Puls, I., Irobi, J., &#x2026; Chance, P. F. (2004). DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). The American Journal of Human Genetics, 74(6), 1128-1135. https://doi.org/10.1086/421054</Citation></Reference><Reference><Citation>Chi, B., O'Connell, J. D., Yamazaki, T., Gangopadhyay, J., Gygi, S. P., &amp; Reed, R. (2018). Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins. Scientific Reports, 8(8755), 8755. https://doi.org/10.1038/s41598-018-27136-3</Citation></Reference><Reference><Citation>&#xc7;i&#xe7;ek, A. E. (2017). k-shell decomposition reveals structural properties of the gene coexpression network for neurodevelopment. Turkish Journal of Biology, 41(2), 333-341. https://doi.org/10.3906/biy-1608-30</Citation></Reference><Reference><Citation>Cirulli, E. T., Lasseigne, B. N., Petrovski, S., Sapp, P. C., Dion, P. a, Leblond, C. S., &#x2026; Goldstein, D. B. (2015). Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science, 347(6229), 1436-1441.</Citation></Reference><Reference><Citation>Cottenie, E., Kochanski, A., Jordanova, A., Bansagi, B., Zimon, M., Horga, A., &#x2026; Houlden, H. (2014). Truncating and missense mutations in IGHMBP2 cause Charcot-Marie tooth disease type 2. American Journal of Human Genetics, 95, 590-601. https://doi.org/10.1016/j.ajhg.2014.10.002</Citation></Reference><Reference><Citation>Cronin, S., Greenway, M. J., Prehn, J. H. M., &amp; Hardiman, O. (2007). Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 78(9), 984-986. https://doi.org/10.1136/jnnp.2006.112581</Citation></Reference><Reference><Citation>Danecek, P., Auton, A., Abecasis, G., Albers, C. A., Banks, E., DePristo, M. A., &#x2026; Durbin, R. (2011). The variant call format and VCFtools. Bioinformatics, 27(15), 2156-2158. https://doi.org/10.1093/bioinformatics/btr330</Citation></Reference><Reference><Citation>Daoud, H., Zhou, S., Noreau, A., Sabbagh, M., Belzil, V., Dionne-laporte, A., &#x2026; Rouleau, G. A. (2012). Exome sequencing reveals SPG11 mutations causing juvenile ALS. NBA, 33(4), 839.e5-839.e9. https://doi.org/10.1016/j.neurobiolaging.2011.11.012</Citation></Reference><Reference><Citation>Davidson, Y. S., Flood, L., Robinson, A. C., Nihei, Y., Mori, K., Rollinson, S., &#x2026; Mann, D. M. A. (2017). Heterogeneous ribonuclear protein A3 (hnRNP A3) is present in dipeptide repeat protein containing inclusions in Frontotemporal Lobar Degeneration and Motor Neurone disease associated with expansions in C9orf72 gene. Acta Neuropathologica Communications, 5(31), 1-10. https://doi.org/10.1186/s40478-017-0437-5</Citation></Reference><Reference><Citation>De Bot, S. T., Veldink, J. H., Vermeer, S., Mensenkamp, A. R., Brugman, F., Scheffer, H., &#x2026; Van De Warrenburg, B. P. (2013). ATL1 and REEP1 mutations in hereditary and sporadic upper motor neuron syndromes. Journal of Neurology, 260(3), 869-875. https://doi.org/10.1007/s00415-012-6723-z</Citation></Reference><Reference><Citation>De Rubeis, S., He, X., Goldberg, A. P., Poultney, C. S., Samocha, K., Cicek, A. E., &#x2026; Buxbaum, J. D. (2014). Synaptic, transcriptional and chromatin genes disrupted in autism. Nature, 515(7526), 209-215. https://doi.org/10.1038/nature13772</Citation></Reference><Reference><Citation>Dekker, A. M., Diekstra, F. P., Pulit, S. L., Tazelaar, G. H. P., van der Spek, R. A., van Rheenen, W., &#x2026; Veldink, J. H. (2019). Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosis. Scientific Reports, 9(1), 3-10. https://doi.org/10.1038/s41598-019-42091-3</Citation></Reference><Reference><Citation>Deschauer, M., Gaul, C., Behrmann, C., Prokisch, H., Zierz, S., &amp; Haack, T. B. (2012). C19orf12 mutations in neurodegeneration with brain iron accumulation mimicking juvenile amyotrophic lateral sclerosis. Journal of Neurology, 259(11), 2434-2439. https://doi.org/10.1007/s00415-012-6521-7</Citation></Reference><Reference><Citation>Dong, C., Wei, P., Jian, X., Gibbs, R., Boerwinkle, E., Wang, K., &amp; Liu, X. (2015). Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. Human Molecular Genetics, 24, 2125-2137. https://doi.org/10.1093/hmg/ddu733</Citation></Reference><Reference><Citation>Elden, A. C., Kim, H. J., Hart, M. P., Chen-Plotkin, A. S., Johnson, B. S., Fang, X., &#x2026; Gitler, A. D. (2010). Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature, 466, 1069-1075. https://doi.org/10.1038/nature09320</Citation></Reference><Reference><Citation>EVS. (2014). Exome variant server. NHLBI GO Exome Sequencing Project (ESP).</Citation></Reference><Reference><Citation>Exome Aggregate Consortium. (2016). ExAC Browser.</Citation></Reference><Reference><Citation>Fifita, J. A., Zhang, K. Y., Galper, J., Williams, K. L., McCann, E. P., Hogan, A. L., &#x2026; Blair, I. P. (2017). Genetic and pathological assessment of hnRNPA1, hnRNPA2/B1, and hnRNPA3 in familial and sporadic amyotrophic lateral sclerosis. Neurodegenerative Diseases, 17(6), 304-312. https://doi.org/10.1159/000481258</Citation></Reference><Reference><Citation>Fogel, B. L., Lee, H., Deignan, J. L., Strom, S. P., Kantarci, S., Wang, X., &#x2026; Nelson, S. F. (2014). Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia. JAMA Neurology, 71(10), 1-10. https://doi.org/10.1001/jamaneurol.2014.1944</Citation></Reference><Reference><Citation>Fogel, B. L., Satya-Murti, S., &amp; Cohen, B. H. (2016). Clinical exome sequencing in neurologic disease: AAN model coverage policy. Neurology: Clinical Practice, 6(2), 164-176. https://doi.org/10.1212/CPJ.0000000000000239</Citation></Reference><Reference><Citation>Frasquet, M., Va, J. F., &amp; Sevilla, T. (2017). The role of DNAJB2 in amyotrophic lateral sclerosis. Brain, 139(10), e57.</Citation></Reference><Reference><Citation>Ghasemi, M., &amp; Brown, R. H. (2018). Genetics of amyotrophic lateral sclerosis. Cold Spring Harbor Perspectives in Medicine, 8(5), 1-38.</Citation></Reference><Reference><Citation>Greenway, M. J., Andersen, P. M., Russ, C., Ennis, S., Cashman, S., Donaghy, C., &#x2026; Green, A. (2006). ANG mutations segregate with familial and &#x2018;sporadic&#x2019; amyotrophic lateral sclerosis. Nature Genetics, 38(4), 2005-2007. https://doi.org/10.1038/ng1742</Citation></Reference><Reference><Citation>Grohmann, K., Schuelke, M., Diers, A., Hoffmann, K., Lucke, B., Adams, C., &#x2026; H&#xfc;bner, C. (2001). Mutations in the gene encoding immunoglobulin &#x3bc;-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nature Genetics, 29, 75-77. https://doi.org/10.1038/ng703</Citation></Reference><Reference><Citation>Guerrero, E. N., Wang, H., Mitra, J., Hegde, P. M., Stowell, S. E., Liachko, N. F., &#x2026; Hegde, M. L. (2016). TDP-43/FUS in motor neuron disease: Complexity and challenges. Progress in Neurobiology, 145-146, 78-97. https://doi.org/10.1016/j.pneurobio.2016.09.004</Citation></Reference><Reference><Citation>Hamzeiy, H., Sava&#x15f;, D., Tunca, C., &#x15e;en, N. E., G&#xfc;ndo&#x11f;du Eken, A., &#x15e;ahbaz, I., &#x2026; Ba&#x15f;ak, A. N. (2018). Elevated global DNA methylation is not exclusive to amyotrophic lateral sclerosis and is also observed in spinocerebellar ataxia types 1 and 2. Neurodegenerative Diseases, 18(1), 38-48. https://doi.org/10.1159/000486201</Citation></Reference><Reference><Citation>Hardiman, O., Al-Chalabi, A., Brayne, C., Beghi, E., Van Den Berg, L. H., Chio, A., &#x2026; Rooney, J. (2017). The changing picture of amyotrophic lateral sclerosis: Lessons from European registers. Journal of Neurology, Neurosurgery and Psychiatry, 88(7), 557-563. https://doi.org/10.1136/jnnp-2016-314495</Citation></Reference><Reference><Citation>Hermosura, M. C., Nayakanti, H., Dorovkov, M. V., Calderon, F. R., Ryazanov, A. G., Haymer, D. S., &amp; Garruto, R. M. (2005). A TRPM7 variant shows altered sensitivity to magnesium that may contribute to the pathogenesis of two Guamanian neurodegenerative disorders. Proceedings of the National Academy of Sciences of the United States of America, 102, 11510-11515. https://doi.org/10.1073/pnas.0505149102</Citation></Reference><Reference><Citation>Huang, D. W., Sherman, B. T., Tan, Q., Collins, J. R., Alvord, W. G., Roayaei, J., &#x2026; Lempicki, R. A. (2007). The DAVID Gene Functional Classification Tool: A novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biology, 8(9), R183. https://doi.org/10.1186/gb-2007-8-9-r183</Citation></Reference><Reference><Citation>H&#xfc;bers, A., Just, W., Rosenbohm, A., M&#xfc;ller, K., Marroquin, N., Goebel, I., &#x2026; Volk, A. E. (2015). De novo FUS mutations are the most frequent genetic cause in early-onset German ALS patients. Neurobiology of Aging, 36(11), 3117.e1-3117.e6. https://doi.org/10.1016/j.neurobiolaging.2015.08.005</Citation></Reference><Reference><Citation>Hughes, C. A., Byrne, P. C., Webb, S., McMonagle, P., Patterson, V., Hutchinson, M., &amp; Parfrey, N. A. (2001). SPG15, a new locus for autosomal recessive complicated HSP on chromosome 14q. Neurology, 56, 1230-1233. https://doi.org/10.1212/WNL.56.9.1230</Citation></Reference><Reference><Citation>Ioannidis, N. M., Rothstein, J. H., Pejaver, V., Middha, S., McDonnell, S. K., Baheti, S., &#x2026; Sieh, W. (2016). REVEL: An ensemble method for predicting the pathogenicity of rare missense variants. American Journal of Human Genetics, 99(4), 877-885. https://doi.org/10.1016/j.ajhg.2016.08.016</Citation></Reference><Reference><Citation>Ionita-Laza, I., Lee, S., Makarov, V., Buxbaum, J. D., &amp; Lin, X. (2013). Sequence kernel association tests for the combined effect of rare and common variants. American Journal of Human Genetics, 92(6), 841-853. https://doi.org/10.1016/j.ajhg.2013.04.015</Citation></Reference><Reference><Citation>Ishiura, H., Sako, W., Yoshida, M., Kawarai, T., Tanabe, O., Goto, J., &#x2026; Tsuji, S. (2012). The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement. American Journal of Human Genetics, 91(2), 320-329. https://doi.org/10.1016/j.ajhg.2012.07.014</Citation></Reference><Reference><Citation>Iskender, C., Kartal, E., Akcimen, F., Kocoglu, C., Kotan, D., Eraksoy, M., &#x2026; Ba&#x15f;ak, A. N. (2015). Turkish families with juvenile motor neuron disease broaden the phenotypic spectrum of SPG11. Neurology: Genetics, 1(3), e25. https://doi.org/10.1212/NXG.0000000000000025</Citation></Reference><Reference><Citation>Janssen, C., Schmalbach, S., Boeselt, S., Sarlette, A., Dengler, R., &amp; Petri, S. (2010). Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis. Journal of Neuropathology and Experimental Neurology, 96(6), 573-581. https://doi.org/10.1097/NEN.0b013e3181ddd404</Citation></Reference><Reference><Citation>Jimeno-Yepes, A. J., Sticco, J. C., Mork, J. G., &amp; Aronson, A. R. (2013). GeneRIF indexing: Sentence selection based on machine learning. BMC Bioinformatics, 14(1), 171. https://doi.org/10.1186/1471-2105-14-171</Citation></Reference><Reference><Citation>Josse, D., Ebel, C., Stroebel, D., Fontaine, A., Borges, F., Echalier, A., &#x2026; Masson, P. (2002). Oligomeric states of the detergent-solubilized human serum paraoxonase (PON1). Journal of Biological Chemistry, 277, 33386-33397. https://doi.org/10.1074/jbc.M200108200</Citation></Reference><Reference><Citation>Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alf&#xf6;ldi, J., Wang, Q., &#x2026; MacArthur, D. G. (2019). Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. BioRxiv, 531210. https://doi.org/10.1101/531210</Citation></Reference><Reference><Citation>Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., &#x2026; Zoing, M. C. (2011). Amyotrophic lateral sclerosis. The Lancet, 377(9769), 942-955. https://doi.org/10.1016/S0140-6736(10)61156-7</Citation></Reference><Reference><Citation>Kimonis, V. E., Fulchiero, E., Vesa, J., &amp; Watts, G. (2008). VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: Review of a unique disorder. Biochimica et Biophysica Acta, 1782(12), 744-748. https://doi.org/10.1016/j.bbadis.2008.09.003</Citation></Reference><Reference><Citation>Kopanos, C., Tsiolkas, V., Kouris, A., Chapple, C. E., Aguilera, M. A., Meyer, R., &amp; Massouras, A. (2019). VarSome: The human genomic variant search engine. Bioinformatics, 35(11), 1978-1980. https://doi.org/10.1093/bioinformatics/bty897</Citation></Reference><Reference><Citation>Lahut, S., &#xd6;m&#xfc;r, &#xd6;., Uyan, &#xd6;., A&#x11f;im, Z. S., &#xd6;zo&#x11f;uz, A., Parman, Y., &#x2026; Ba&#x15f;ak, A. N. (2012). ATXN2 and its neighbouring gene SH2B3 are associated with increased ALS risk in the Turkish population. PLoS One, 7(8), e42956. https://doi.org/10.1371/journal.pone.0042956</Citation></Reference><Reference><Citation>Lamp, M., Origone, P., Geroldi, A., Verdiani, S., Gotta, F., Caponnetto, C., &#x2026; Mandich, P. (2018). Twenty years of molecular analyses in amyotrophic lateral sclerosis: Genetic landscape of Italian patients. Neurobiology of Aging, 66, 179.e5-179.e16. https://doi.org/10.1016/j.neurobiolaging.2018.01.013</Citation></Reference><Reference><Citation>Landers, J. E., Shi, L., Cho, T. J., Glass, J. D., Shaw, C. E., Leigh, P. N., &#x2026; Brown, R. H. (2008). A common haplotype within the PON1 promoter region is associated with sporadic ALS. Amyotrophic Lateral Sclerosis, 9(5), 306-314. https://doi.org/10.1080/17482960802233177</Citation></Reference><Reference><Citation>Landrum, M. J., Lee, J. M., Riley, G. R., Jang, W., Rubinstein, W. S., Church, D. M., &amp; Maglott, D. R. (2014). ClinVar: Public archive of relationships among sequence variation and human phenotype. Nucleic Acids Research, 42, D980-D985. https://doi.org/10.1093/nar/gkt1113</Citation></Reference><Reference><Citation>Lazo-G&#xf3;mez, R., Ram&#xed;rez-Jarqu&#xed;n, U. N., Tovar-y-Romo, L. B., &amp; Tapia, R. (2013). Histone deacetylases and their role in motor neuron degeneration. Frontiers in Cellular Neuroscience, 7(243), 1-7. https://doi.org/10.3389/fncel.2013.00243</Citation></Reference><Reference><Citation>Leblond, C. S., Webber, A., Gan-Or, Z., Moore, F., Dagher, A., Dion, P. A., &amp; Rouleau, G. A. (2016). De novo FUS P525L mutation in Juvenile amyotrophic lateral sclerosis with dysphonia and diplopia. Neurology: Genetics, 2(2), e63. https://doi.org/10.1212/NXG.0000000000000063</Citation></Reference><Reference><Citation>Li, H., &amp; Durbin, R. (2009). Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics, 25(14), 1754-1760. https://doi.org/10.1093/bioinformatics/btp324</Citation></Reference><Reference><Citation>Li, Q., Velde, C., Vande, Israelson, A., Xie, J., Bailey, A. O., Dong, M. Q., &#x2026; Miller, T. M. (2010). ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proceedings of the National Academy of Sciences of the United States of America, 107(49), 21146-21151. https://doi.org/10.1073/pnas.1014862107</Citation></Reference><Reference><Citation>Liu, L., Lei, J., &amp; Roeder, K. (2015). Network assisted analysis to reveal the genetic basis of autism. Annals of Applied Statistics, 9(3), 1571-1600. https://doi.org/10.1214/15-AOAS844</Citation></Reference><Reference><Citation>Liu, L., Lei, J., Sanders, S. J., Willsey, A. J., Kou, Y., Cicek, A. E., &#x2026; Roeder, K. (2014). DAWN: A framework to identify autism genes and subnetworks using gene expression and genetics. Molecular Autism, 5, 1-22. https://doi.org/10.1186/2040-2392-5-22</Citation></Reference><Reference><Citation>Majounie, E., Renton, A. E., Mok, K., Dopper, E. G. P., Waite, A., Rollinson, S., &#x2026; Traynor, B. J. (2012). Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: A cross-sectional study. The Lancet Neurology, 11(4), 323-330. https://doi.org/10.1016/S1474-4422(12)70043-1</Citation></Reference><Reference><Citation>Maruyama, H., Morino, H., Ito, H., Izumi, Y., Kato, H., Watanabe, Y., &#x2026; Kawakami, H. (2010). Mutations of optineurin in amyotrophic lateral sclerosis. Nature, 465(7295), 223-226. https://doi.org/10.1038/nature08971</Citation></Reference><Reference><Citation>Maystadt, I., Rezs&#xf6;hazy, R., Barkats, M., Duque, S., Vannuffel, P., Remacle, S., &#x2026; Verellen-Dumoulin, C. (2007). The nuclear factor &#x3ba;B-activator gene PLEKHG5 is mutated in a form of autosomal recessive lower motor neuron disease with childhood onset. The American Journal of Human Genetics, 81(1), 67-76. https://doi.org/10.1086/518900</Citation></Reference><Reference><Citation>McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., &#x2026; DePristo, M. A. (2010). The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Research, 20(9), 1297-1303. https://doi.org/10.1101/gr.107524.110</Citation></Reference><Reference><Citation>McLaren, W., Gil, L., Hunt, S. E., Riat, H. S., Ritchie, G. R. S., Thormann, A., &#x2026; Cunningham, F. (2016). The Ensembl variant effect predictor. Genome Biology, 17(122), 1-14. https://doi.org/10.1186/s13059-016-0974-4</Citation></Reference><Reference><Citation>Menini, T., &amp; Gugliucci, A. (2014). Paraoxonase 1 in neurological disorders. Redox Report, 19(2), 49-58. https://doi.org/10.1179/1351000213Y.0000000071</Citation></Reference><Reference><Citation>Merwin, S. J., Obis, T., Nunez, Y., &amp; Re, D. B. (2017). Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: The known, the misknown, and the unknown. Archives of Toxicology, 91(8), 2939-2952. https://doi.org/10.1007/s00204-016-1926-1</Citation></Reference><Reference><Citation>Muriel, M. P., Dauphin, A., Namekawa, M., Gervais, A., Brice, A., &amp; Ruberg, M. (2009). Atlastin-1, the dynamin-like GTPase responsible for spastic paraplegia SPG3A, remodels lipid membranes and may form tubules and vesicles in the endoplasmic reticulum. Journal of Neurochemistry, 110(5), 1607-1616. https://doi.org/10.1111/j.1471-4159.2009.06258.x</Citation></Reference><Reference><Citation>Nalini, A., Pandraud, A., Mok, K., &amp; Houlden, H. (2013). Madras motor neuron disease (MMND) is distinct from the riboflavin transporter genetic defects that cause Brown-Vialetto-Van Laere syndrome. Journal of the Neurological Sciences, 334(1-2), 119-122. https://doi.org/10.1016/j.jns.2013.08.003</Citation></Reference><Reference><Citation>Nguyen, H. P., Van Broeckhoven, C., &amp; van der Zee, J. (2018). ALS genes in the genomic era and their implications for FTD. Trends in Genetics, 34(6), 404-423. https://doi.org/10.1016/j.tig.2018.03.001</Citation></Reference><Reference><Citation>Nguyen, M. D., Boudreau, M., Kriz, J., Couillard-Despr&#xe9;s, S., Kaplan, D. R., &amp; Julien, J. P. (2003). Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1. Journal of Neuroscience, 23(6), 2131-2140.</Citation></Reference><Reference><Citation>Nicolas, A., Kenna, K. P., Renton, A. E., Ticozzi, N., Faghri, F., Chia, R., &#x2026; Traynor, B. J. (2018). Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron, 97(6), 1268-1283.e6. https://doi.org/10.1016/j.neuron.2018.02.027</Citation></Reference><Reference><Citation>Norman, U., &amp; Cicek, A. E. (2019). ST-Steiner: A spatio-temporal gene discovery algorithm. Bioinformatics, 35(18), 3433-3440. https://doi.org/10.1093/bioinformatics/btz110</Citation></Reference><Reference><Citation>Ogaki, K., Li, Y., Atsuta, N., Tomiyama, H., Funayama, M., Watanabe, H., &#x2026; Sobue, G. (2012). Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis. Neurobiology of Aging, 33(10), 11-16. https://doi.org/10.1016/j.neurobiolaging.2012.05.011</Citation></Reference><Reference><Citation>&#xd6;zo&#x11f;uz, A., Uyan, &#xd6;., Birdal, G., Iskender, C., Kartal, E., Lahut, S., &#x2026; Ba&#x15f;ak, A. N. (2015). The distinct genetic pattern of ALS in Turkey and novel mutations. Neurobiology of Aging, 36(4), 1764.e9-1764.e18. https://doi.org/10.1016/j.neurobiolaging.2014.12.032</Citation></Reference><Reference><Citation>Par&#xe9;, B., Lehmann, M., Beaudin, M., Nordstr&#xf6;m, U., Saikali, S., Julien, J. P., &#x2026; Gros-Louis, F. (2018). Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis. Scientific Reports, 8(14223), https://doi.org/10.1038/s41598-018-31773-z</Citation></Reference><Reference><Citation>Pharaoh, G., Sataranatarajan, K., Street, K., Hill, S., Gregston, J., Ahn, B., &#x2026; Van Remmen, H. (2019). Metabolic and stress response changes precede disease onset in the spinal cord of mutant SOD1 ALS mice. Frontiers in Neuroscience, 13(487), https://doi.org/10.3389/fnins.2019.00487</Citation></Reference><Reference><Citation>Pi&#xf1;ero, J., Bravo, &#xc0;., Queralt-Rosinach, N., Guti&#xe9;rrez-Sacrist&#xe1;n, A., Deu-Pons, J., Centeno, E., &#x2026; Furlong, L. I. (2017). DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Research, 45(D1), D833-D839. https://doi.org/10.1093/nar/gkw943</Citation></Reference><Reference><Citation>Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., &#x2026; Sham, P. C. (2007). PLINK: A tool set for whole-genome association and population-based linkage analyses. The American Journal of Human Genetics, 81(3), 559-575. https://doi.org/10.1086/519795</Citation></Reference><Reference><Citation>Raczy, C., Petrovski, R., Saunders, C. T., Chorny, I., Kruglyak, S., Margulies, E. H., &#x2026; Tanner, S. W. (2013). Isaac: Ultra-fast whole-genome secondary analysis on Illumina sequencing platforms. Bioinformatics, 29(16), 2041-2043. https://doi.org/10.1093/bioinformatics/btt314</Citation></Reference><Reference><Citation>Ranganathan, S., &amp; Bowser, R. (2003). Alterations in G1 to S phase cell-cycle regulators during amyotrophic lateral sclerosis. American Journal of Pathology, 162(3), 823-835. https://doi.org/10.1016/S0002-9440(10)63879-5</Citation></Reference><Reference><Citation>Rossaert, E., Pollari, E., Jaspers, T., Van Helleputte, L., Jarpe, M., Van Damme, P., &#x2026; Van Den Bosch, L. (2019). Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model. Acta Neuropathologica Communications, 7(107), 1-19. https://doi.org/10.1186/s40478-019-0750-2</Citation></Reference><Reference><Citation>Saccon, R. A., Bunton-Stasyshyn, R. K. A., Fisher, E. M. C., &amp; Fratta, P. (2013). Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain, 136(8), 2342-2358. https://doi.org/10.1093/brain/awt097</Citation></Reference><Reference><Citation>Sanders, S. J., He, X., Willsey, A. J., Ercan-Sencicek, A. G., Samocha, K. E., Cicek, A. E., &#x2026; State, M. W. (2015). Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci. Neuron, 87(6), 1215-1233. https://doi.org/10.1016/j.neuron.2015.09.016</Citation></Reference><Reference><Citation>Smith, B. N., Newhouse, S., Shatunov, A., Vance, C., Topp, S., Johnson, L., &#x2026; Shaw, C. E. (2013). The C9ORF72 expansion mutation is a common cause of ALS+/&#x2212;FTD in Europe and has a single founder. European Journal of Human Genetics, 21(1), 102-108. https://doi.org/10.1038/ejhg.2012.98</Citation></Reference><Reference><Citation>Smith, B. N., Topp, S. D., Fallini, C., Shibata, H., Chen, H. J., Troakes, C., &#x2026; Shaw, C. E. (2017). Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis. Science Translational Medicine, 9(388), eaad9157. Retrieved from https://csic.gtbib.net/menu_usuario.php?centro=CSIC&amp;p=I0dUZFhOMVlYSnBiMTl3WlhScFkybHZibVZ6TG5Cb2NBPT0=&amp;campo=PETICION&amp;texto=13709134&amp;export=mendeley</Citation></Reference><Reference><Citation>Stoll, M., Teoh, H., Lee, J., Reddel, S., Zhu, Y., Buckley, M., &#x2026; Nicholson, G. (2016). Novel motor phenotypes in patients with VRK1 mutations without pontocerebellar hypoplasia. Neurology, 87(1), 65-70. https://doi.org/10.1212/WNL.0000000000002813</Citation></Reference><Reference><Citation>Sumner, C. J., D'Ydewalle, C., Wooley, J., Fawcett, K. A., Hernandez, D., Gardiner, A. R., &#x2026; Houlden, H. (2013). A dominant mutation in FBXO38 causes distal spinal muscular atrophy with calf predominance. American Journal of Human Genetics, 93(5), 976-983. https://doi.org/10.1016/j.ajhg.2013.10.006</Citation></Reference><Reference><Citation>Sunkin, S. M., Ng, L., Lau, C., Dolbeare, T., Gilbert, T. L., Thompson, C. L., &#x2026; Dang, C. (2013). Allen Brain Atlas: An integrated spatio-temporal portal for exploring the central nervous system. Nucleic Acids Research, 41(Database issue), D996-D1008. https://doi.org/10.1093/nar/gks1042</Citation></Reference><Reference><Citation>Synofzik, M., Ronchi, D., Keskin, I., Basak, A. N., Wilhelm, C., Gobbi, C., &#x2026; Andersen, P. M. (2012). Mutant superoxide dismutase-1 indistinguishable from wild-type causes ALS. Human Molecular Genetics, 21(16), 3568-3574. https://doi.org/10.1093/hmg/dds188</Citation></Reference><Reference><Citation>Synofzik, M., Smets, K., Mallaret, M., Di Bella, D., Gallenm&#xfc;ller, C., Baets, J., &#x2026; Bauer, P. (2016). SYNE1 ataxia is a common recessive ataxia with major non-cerebellar features: A large scale multi-centre study. Brain, 138(5), 1378-1393. https://doi.org/10.1093/brain/aww079</Citation></Reference><Reference><Citation>Takahashi, Y., Fukuda, Y., Yoshimura, J., Toyoda, A., Kurppa, K., Moritoyo, H., &#x2026; Tsuji, S. (2013). ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis Type 19. American Journal of Human Genetics, 93(5), 900-905. https://doi.org/10.1016/j.ajhg.2013.09.008</Citation></Reference><Reference><Citation>Teer, J. K., Green, E. D., Mullikin, J. C., &amp; Biesecker, L. G. (2012). VarSifter: Visualizing and analyzing exome-scale sequence variation data on a desktop computer. Bioinformatics, 28(4), 599-600. https://doi.org/10.1093/bioinformatics/btr711</Citation></Reference><Reference><Citation>Therrien, M., Dion, P. A., &amp; Rouleau, G. A. (2016). ALS: Recent developments from genetics studies. Current Neurology and Neuroscience Reports, 16(6), 59. https://doi.org/10.1007/s11910-016-0658-1</Citation></Reference><Reference><Citation>Ticozzi, N., LeClerc, A. L., Keagle, P. J., Glass, J. D., Wills, A. M., Van Blitterswijk, M., &#x2026; Landers, J. E. (2010). Paraoxonase gene mutations in amyotrophic lateral sclerosis. Annals of Neurology, 68(1), 102-107. https://doi.org/10.1002/ana.21993</Citation></Reference><Reference><Citation>Torkamani, A., Dean, B., Schork, N. J., &amp; Thomas, E. A. (2010). Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia. Genome Research, 20(4), 403-412. https://doi.org/10.1101/gr.101956.109</Citation></Reference><Reference><Citation>Trujillano, D., Bertoli-Avella, A. M., Kumar Kandaswamy, K., Weiss, M. E., K&#xf6;ster, J., Marais, A., &#x2026; Abou Jamra, R. (2017). Clinical exome sequencing: Results from 2819 samples reflecting 1000 families. European Journal of Human Genetics, 25(2), 176-182. https://doi.org/10.1038/ejhg.2016.146</Citation></Reference><Reference><Citation>Tunca, C., Ak&#xe7;imen, F., Co&#x15f;kun, C., G&#xfc;ndo&#x11f;du-Eken, A., Kocoglu, C., &#xc7;evik, B., &#x2026; Ba&#x15f;ak, A. N. (2018). ERLIN1 mutations cause teenage-onset slowly progressive ALS in a large Turkish pedigree. European Journal of Human Genetics, 26(5), 745-748. https://doi.org/10.1038/s41431-018-0107-5</Citation></Reference><Reference><Citation>van Blitterswijk, M., van Es, M., Hennekam, E. M., Dooijes, D., van Rheenen, W., Medic, J., &#x2026; van den Berg, L. H. (2012). Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Human Molecular Genetics, 21(17), 3776-3784. https://doi.org/10.1093/hmg/dds199</Citation></Reference><Reference><Citation>van der Spek, R. A. A., van Rheenen, W., Pulit, S. L., Kenna, K. P., McLaughlin, R. L., Moisse, M., &#x2026; Veldink, J. H. (2019). The Project MinE databrowser: Bringing large-scale whole-genome sequencing in ALS to researchers and the public. BioRxiv, 20(5-6), 432-440. https://doi.org/10.1101/377911</Citation></Reference><Reference><Citation>van Es, M. A., Hardiman, O., Chio, A., Al-Chalabi, A., Pasterkamp, R. J., Veldink, J. H., &amp; van den Berg, L. H. (2017). Amyotrophic lateral sclerosis. The Lancet, 4(390), 2084-2098. https://doi.org/10.1016/S0140-6736(17)31287-4</Citation></Reference><Reference><Citation>van Rheenen, W., Pulit, S. L., Dekker, A. M., Al Khleifat, A., Brands, W. J., Iacoangeli, A., &#x2026; Project MinE ALS Sequencing Consortium (2018). Project MinE: Study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. European Journal of Human Genetics, 26(10), 1537-1546. https://doi.org/10.1038/s41431-018-0177-4</Citation></Reference><Reference><Citation>van Rheenen, W., Shatunov, A., Dekker, A. M., McLaughlin, R. L., Diekstra, F. P., Pulit, S. L., &#x2026; Veldink, J. H. (2016). Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nature Genetics, 48(9), 1043-1048. https://doi.org/10.1038/ng.3622</Citation></Reference><Reference><Citation>Velilla, J., Marchetti, M. M., Toth-Petroczy, A., Grosgogeat, C., Bennett, A. H., Carmichael, N., &#x2026; Gupta, V. A. (2019). Homozygous TRPV4 mutation causes congenital distal spinal muscular atrophy and arthrogryposis. Neurology: Genetics, 5(2), 312. https://doi.org/10.1212/NXG.0000000000000312</Citation></Reference><Reference><Citation>Verde, F., Tiloca, C., Morelli, C., Doretti, A., Poletti, B., Maderna, L., &#x2026; Ticozzi, N. (2019). PON1 is a disease modifier gene in amyotrophic lateral sclerosis: Association of the Q192R polymorphism with bulbar onset and reduced survival. Neurological Sciences, 40, 1469-1473. https://doi.org/10.1007/s10072-019-03834-2</Citation></Reference><Reference><Citation>Wang, K., Li, M., &amp; Hakonarson, H. (2010). ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Research, 38(16), 1-7. https://doi.org/10.1093/nar/gkq603</Citation></Reference><Reference><Citation>Wills, A. M., Cronin, S., Slowik, A., Kasperaviciute, D., Van Es, M. A., Morahan, J. M., &#x2026; Brown, R. H. (2009). A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology, 73(1), 16-24. https://doi.org/10.1212/WNL.0b013e3181a18674</Citation></Reference><Reference><Citation>Winton, M. J., Van Deerlin, V. M., Kwong, L. K., Yuan, W., Wood, E. M., Yu, C., &#x2026; Lee, M. (2009). A90V TDP-43 variant results in the aberrant localization of TDP-43 in vitro. FEBS Letters, 582(15), 2252-2256.</Citation></Reference><Reference><Citation>Wobst, H. J., Wesolowski, S. S., Chadchankar, J., Delsing, L., Jacobsen, S., Mukherjee, J., &#x2026; Moss, S. J. (2017). Cytoplasmic relocalization of TAR DNA-binding protein 43 is not sufficient to reproduce cellular pathologies associated with ALS in vitro. Frontiers in Molecular Neuroscience, 10, 1-13. https://doi.org/10.3389/fnmol.2017.00046</Citation></Reference><Reference><Citation>Yang, Y., Hentati, A., Deng, H. X., Dabbagh, O., Sasaki, T., Hirano, M., &#x2026; Siddique, T. (2001). The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nature Genetics, 29(2), 160-165. https://doi.org/10.1038/ng1001-160</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>